Introducing principles of validation into biochemistry and biotechnology courses: Practical concepts and a framework for active learning

Biochemistry and Molecular Biology Education

Volumn 36, Issue 1, 2008, Pages 70-75

  Pembroke, J T ^a  

^a UNIVERSITY OF LIMERICK   (Ireland)

Author keywords

Methodology; Regulatory issues; Validation

Indexed keywords

EID: 38949166769     PISSN: 14708175     EISSN: None     Source Type: Journal    
DOI: 10.1002/bmb.130     Document Type: Short Survey

References (13)

1. R. Gengenbach (2006) FDA-compliant qualification of manufacturing plants for active pharmaceutical ingredients, Pharm. Ind. 68, 987-994.
2. F. J. Carleton, J. P. Agalloco, Eds. (1998) Validation of Pharmaceutical Processes, Marcel Dekker, New York; ISBN: 0824793846.
3. R. Kirrstetter (2004) FDA inspections of drug products and active pharmaceutical ingredients, Pharm. Ind. 66, 1260.
4. O. Doblhoff-Dier, R. Bliem (1999) Quality control and assurance from the development to the production of biopharmaceuticals, Trends. Biotechnol. 17, 266-270.
5. S. I. Haider (2002) Pharmaceutical Master Validation Plan: The Ultimate Guide to FDA, GMP, and GLP Compliance, St Lucie Press, Boca Raton, FL; ISBN 1-57444-330-5.
6. J. Agalloco, G. Sofer (2000) Master planning and validation, Part 1: Anatomy of a validation master plan, Biopharm. Appl. Tech. Biopharm. Dev. 13, 10-10 A.
7. C. Oechslein (2004) cGMP aspects in practice: Basics for the compilation of a validation master plan, Pharm. Ind. 66, 769-770.
8. P. Bruce, P. Minkkinen, M. L. Riekkola (1998) Practical method validation: Validation sufficient for an analysis method, Mikromol. Chem. Acta 128, 93-106.
9. G. A. Shabir, W. J. Lough, S. A. Arain, T. K. Bradshaw (2007) Evaluation and application of best practice in analytical method validation, J. Liq. Chrom. Relat. Technol. 30, 311-333.
10. H. Aleem, Y. Zhao, S. Lord, T. McCarty, P. Sharrett (2003) Pharmaceutical process validation: An overview, Proc. Inst. Mech. Eng. Part E: J. Proc. Mech. Eng. 217, 141-151.
11. K. A. Welch, C. A. Fling, S. R. Schmidt (2004) Risk/science-based approach to validation: A win-win-win for patients, regulators, and industry, PDA J. Pharm. Sci. Technol. 58, 15-23.
12. E. C. Tidswell (2005) Bacterial adhesion: Considerations within a risk-based approach to cleaning validation, PDA J. Pharm. Sci. Technol. 59, 10-32.
13. C. Schonborn (2003) GMP requirements for quality control/assurance in the manufacturing of active pharmaceutical ingredients examples from manufacturing plants, Pharm. Ind. 65, 695.